Discontinued drugs in 2006: oncology drugs

Abstract

This perspective is the last in a series of papers discussing drugs dropped from clinical development in 2006. Specifically, this paper focuses on the 16 drugs discontinued for the treatment of cancer, the largest area of pharma R&D. This was based on a search of the Pharmaprojects database for drugs reaching Phase I – III clinical trials.

Keywords::

• atamestane
• AZD-3409
• AZD-5438
• BW-114
• canertinib dihydrochloride
• del-1
• DJ-927
• G-024856
• INNO-105
• MG-98
• MLN-2704
• NS-3728
• PANVAC-VF
• PX-104.1
• SK-962
• WP-760

Acknowledgement

The author would like to thank A Treadway, Expert Opinion, Informa Healthcare, for the extraction of information required for preparation of this manuscript.